Company Profile
Public information reviewedAgomab Therapeutics NV
AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies.
USNASDAQ: AGMB
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 0
- Last reviewed
- Sep 14, 2026

